* Prestige Consumer Healthcare Inc PBH.N reported
quarterly
adjusted earnings of 98 cents per share for the quarter ended
in March, higher than the same quarter last year, when the
company reported EPS of $-4.83. The mean expectation of
six analysts for the quarter was for earnings of $1.14 per
share. Wall Street expected results to range from $1.14 to
* Revenue fell 3.1% to $276.99 million from a year ago;
analysts
expected $287.47 million.
* Prestige Consumer Healthcare Inc's reported EPS for the
quarter
was 98 cents.
* The company reported quarterly net income of $49.46
million.
* Prestige Consumer Healthcare Inc shares had fallen by 2.8%
this
quarter and gained 15.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Prestige Consumer
Healthcare Inc is $75.00
This summary was machine generated from LSEG data May 15 at
12:39 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 1.14 0.98 Missed
Dec. 31 2023 1.04 1.06 Beat
Sep. 30 2023 1.07 1.07 Met
Jun. 30 2023 1.01 1.06 Beat